MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,198,919 | $283,814,000 | 82.63% |
| BB BIOTECH AG | 1,274,706 | $164,526,000 | 4.90% |
| Selkirk Management LLC | 64,300 | $8,299,000 | 4.61% |
| Opus Point Partners Management, LLC | 30,747 | $3,969,000 | 3.33% |
| Arlington Capital Management, Inc. | 28,845 | $3,723,000 | 2.67% |
| Orbimed Advisors | 2,348,900 | $303,173,000 | 2.59% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 70,900 | $9,151,000 | 2.44% |
| HealthCor Management, L.P. | 375,000 | $48,401,000 | 2.31% |
| BENDER ROBERT & ASSOCIATES | 27,084 | $3,496,000 | 2.04% |
| Eventide Asset Management | 208,200 | $26,872,000 | 2.02% |